TRICCAR products are backed by over $68,000,000 in research, double-blind placebo-based testing and clinical studies. We primarily focus on natural solutions to support those facing illness and disease.
Our products include:
We are currently working on bioceutical solutions that support post traumatic stress disorder (PTSD), alleviate persistent headaches, and a new formula we are very excited about that may prove beneficial in removing glyphosate (the active ingredient in the pesticide Roundup™) from the human body.
TRICCAR's VP of Department of Justice and Drug Enforcement Administration (DEA) is a 30+ year veteran of the DEA, most recently serving as head of global operations. Any products the company brings to market that include extracts of cannabis is under the guidance of the DEA. TRICCAR has developed several formulae that we hope to introduce as bioceuticals if federal cannabis laws become clearer and the use of hemp extracts in supplements, including truth in labeling laws, is approved by the DEA and FDA. These include:
CBX™ The highest percentage by volume of full spectrum CBD in an over the counter supplement
CBZ™ A full spectrum cannabidiol and terpene-based sleep aid
CBT™ A topical nerve and muscle pain relief formula leveraging proprietary science that leverages the skin as a portal for systemic delivery
ZZZ™ Sleep support (FDA Approval may be required)
NRV™ Nerve Pain (FDA Approval may be required)
CTX™ Chronic Traumatic Encephalopathy (FDA approval may be required)
Some of our formula will require full clinical testing and FDA approval as pharmaceuticals. We will partner with larger pharmaceutical companies to bring these through the FDA process.
ALX™ Amyotrophic Lateral Sclerosis (FDA Approval required)
DIA™ Diabetic Nerve Pain (FDA Approval required)
Formulae 40, 46, 48, & 50 Cancers (FDA Approval required)
Several of our formulae have already adapted to Animal Science, primarily in the areas of performance and nutrition for equine, canine and feline.
Most of our products contain Polyamorphic Hipotomanine™, a proprietary natural formula that we developed that aids in absorption of our formula ingredients.
To learn more about our products, contact us.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Test results are available upon signing of a non-disclosure agreement and approval of TRICCAR management. User results and opinions of user experiences are the sole opinions of people who used these formula/ae and are not to be construed as claims made by TRICCAR, Inc.
Copyright © 2014 -2021 TRICCAR Holdings , Inc. - All Rights Reserved.
TRICCAR, the TRICCAR mark, TRICCAR Holdings, Townsend Rockefeller Institute for Cannabis Cultivation and Research are copyrights and/or trademarks of TRICCAR Holdings, Inc.
No part of this site may be reproduced without written permission.
These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. Test results are available upon signing of a non-disclosure agreement and approval of TRICCAR management. User results and opinions of user experiences are the sole opinions of people who used these formula/ae and are not to be construed as claims made by TRICCAR or its affiliates.
Contact us at Hope @ TRICCAR . com
TRICCAR takes the spread of viruses seriously. We are ramping production of our AVL™ antiviral and IMX™ immunity support products to make them available to governments and health care oriented nonprofits and NGOs.